Rajamanickam S, Agarwal R. Natural products and colon cancer: current status and future prospects. Drug Dev Res. 2008;69(7):460–71.
CAS PubMed PubMed Central Google Scholar
Wu YJ, Cai ZQ, He RM, Wang XC, Cong LL, Qiu FH. Knockdown of long noncoding RNA 01124 inhibits the malignant behaviors of colon cancer cells via miR-654-5p/HAX-1. Evid Based Complement Alternat Med. 2022;2022:1092107.
PubMed PubMed Central Google Scholar
Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Farkas L, et al. Colon cancer, Version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329–59.
Ma L, Li Y, Peng J, Wu D, Zhao X, Cui Y, Chen L, Yan X, Du Y, Yu L. Discovery of the migrasome, an organelle mediating release of cytoplasmic contents during cell migration. Cell Res. 2015;25(1):24–38.
Zhao X, Lei Y, Zheng J, Peng J, Li Y, Yu L, Chen Y. Identification of markers for migrasome detection. Cell Discov. 2019;5:27.
CAS PubMed PubMed Central Google Scholar
Wu D, Xu Y, Ding T, Zu Y, Yang C, Yu L. Pairing of integrins with ECM proteins determines migrasome formation. Cell Res. 2017;27(11):1397–400.
CAS PubMed PubMed Central Google Scholar
Jiang D, Jiang Z, Lu D, Wang X, Liang H, Zhang J, Meng Y, Li Y, Wu D, Huang Y, et al. Migrasomes provide regional cues for organ morphogenesis during zebrafish gastrulation. Nat Cell Biol. 2019;21(8):966–77.
Zhang R, Peng J, Zhang Y, Zheng K, Chen Y, Liu L, Li T, Liu J, Li Y, Yang S, et al. Pancreatic cancer cell-derived migrasomes promote cancer progression by fostering an immunosuppressive tumor microenvironment. Cancer Lett. 2024;605: 217289.
Sun L, Yu J, Wang P, Shen M, Ruan S. HIT000218960 promotes gastric cancer cell proliferation and migration through upregulation of HMGA2 expression. Oncol Lett. 2019;17(6):4957–63.
CAS PubMed PubMed Central Google Scholar
Yang S, Chen J, Yu Y, Li D, Huang M, Yuan L, Yin G. Long noncoding RNA ROR as a novel biomarker for progress and prognosis outcome in human cancer: a meta-analysis in the Asian population. Cancer Manag Res. 2018;10:4641–52.
CAS PubMed PubMed Central Google Scholar
Cai J, Ji Z, Wu J, Chen L, Zheng D, Chen Y, Zhang X, Xie W, Huang J, Chen M, et al. Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer. Front Genet. 2022;13: 949314.
CAS PubMed PubMed Central Google Scholar
Wang K, Yu J, Xu Q, Peng Y, Li H, Lu Y, Ouyang M. Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma. Apoptosis. 2024;71:209.
Qin Y, Yang J, Liang C, Liu J, Deng Z, Yan B, Fu Y, Luo Y, Li X, Wei X, et al. Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: a bulk omics research and single cell sequencing validation. Front Immunol. 2022;13: 994828.
CAS PubMed PubMed Central Google Scholar
Zheng Y, Lang Y, Qi B, Li T. TSPAN4 and migrasomes in atherosclerosis regression correlated to myocardial infarction and pan-cancer progression. Cell Adh Migr. 2023;17(1):14–9.
Sagaert X, Vanstapel A, Verbeek S. Tumor heterogeneity in colorectal cancer: what do we know so far? Pathobiology. 2018;85(1–2):72–84.
da Rocha-Azevedo B, Schmid SL. Migrasomes: a new organelle of migrating cells. Cell Res. 2015;25(1):1–2.
Chen L, Ma L, Yu L. WGA is a probe for migrasomes. Cell Discov. 2019;5:13.
CAS PubMed PubMed Central Google Scholar
Saito S, Tanaka M, Tatematsu S, Okochi M. Peptide-modified substrate enhances cell migration and migrasome formation. Mater Sci Eng C Mater Biol Appl. 2021;131: 112495.
Yang C, Hu JF, Zhan Q, Wang ZW, Li G, Pan JJ, Huang L, Liao CY, Huang Y, Tian YF, et al. SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer. Genomics. 2021;113(2):827–42.
Yu S, Yu L. Migrasome biogenesis and functions. FEBS J. 2022;289(22):7246–54.
Jiao H, Jiang D, Hu X, Du W, Ji L, Yang Y, Li X, Sho T, Wang X, Li Y, et al. Mitocytosis, a migrasome-mediated mitochondrial quality-control process. Cell. 2021;184(11):2896–910.
Cao J, Wu L, Lei X, Shi K, Shi L, Shi Y. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma. Bioengineered. 2021;12(1):673–81.
CAS PubMed PubMed Central Google Scholar
Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–81.
CAS PubMed PubMed Central Google Scholar
Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond). 2021;41(2):109–20.
Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–7.
CAS PubMed PubMed Central Google Scholar
Wang W, Liu Y, Wang Z, Tan X, Jian X, Zhang Z. Exploring and validating the necroptotic gene regulation and related lncRNA mechanisms in colon adenocarcinoma based on multi-dimensional data. Sci Rep. 2024;14(1):22251.
CAS PubMed PubMed Central Google Scholar
Kim Z, Lee J, Yoon YE, Yun JW. Unveiling prognostic RNA biomarkers through a multi-cohort study in colorectal cancer. Int J Mol Sci. 2024;25(6):3317.
CAS PubMed PubMed Central Google Scholar
Chen X, Ye Z, Lou P, Liu W, Liu Y. Comprehensive analysis of metabolism-related lncRNAs related to the progression and prognosis in osteosarcoma from TCGA. J Orthop Surg Res. 2021;16(1):523.
PubMed PubMed Central Google Scholar
Hu D, Messadi DV. Immune-related long non-coding RNA signatures for tongue squamous cell carcinoma. Curr Oncol. 2023;30(5):4817–32.
PubMed PubMed Central Google Scholar
Xu Q, Liu T, Wang J. Radiosensitization-related cuproptosis LncRNA signature in non-small cell lung cancer. Genes (Basel). 2022;13(11):2080.
Liu J, Ye L, Li Q, Wu X, Wang B, Ouyang Y, Yuan Z, Li J, Lin C. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity. J Pathol. 2018;244(1):71–83.
Gan W, Dai X, Dai X, Xie J, Yin S, Zhu J, Wang C, Liu Y, Guo J, Wang M, et al. LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control. Nat Cell Biol. 2020;22(2):246–56.
CAS PubMed PubMed Central Google Scholar
Zhang J, Wang G, Chu SJ, Zhu JS, Zhang R, Lu WW, Xia LQ, Lu YM, Da W, Sun Q. Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling. Oncotarget. 2016;7(13):16180–93.
PubMed PubMed Central Google Scholar
Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD, et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A. 2011;108(49):E1312-1320.
CAS PubMed PubMed Central Google Scholar
Shen Z, Pan Y, Chen P, Jiang B, Fang X, Jiang Y. LATS1 exerts tumor suppressor functions via targeting Gli1 in colorectal cancer. J Cancer. 2021;12(24):7311–9.
Comments (0)